Stoke Therapeutics
STOK
STOK
96 hedge funds and large institutions have $372M invested in Stoke Therapeutics in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 34 increasing their positions, 40 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 107 → 96 (-11)
15% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 40
69% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 16
Holders
96
Holding in Top 10
3
Calls
$120K
Puts
$14K
Top Buyers
| 1 | +$29.2M | |
| 2 | +$21.1M | |
| 3 | +$8.38M | |
| 4 |
RI
RTW Investments
New York
|
+$4.33M |
| 5 |
Morgan Stanley
New York
|
+$3.92M |
Top Sellers
| 1 | -$8.88M | |
| 2 | -$4.81M | |
| 3 | -$3.96M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.92M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$3.64M |